|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Contraceptives for lactating women: a comparative trial of a progesterone- |
| releasing vaginal ring and the Copper T 380A IUD. |
| Sivin I; Diaz S; Croxatto HB; Miranda P; Shaaban M; Sayed EH; Xiao B; Wu |
| CONTRACEPTION. 1997 Apr;55(4):225-32. |
| A multicenter trial conducted in nine clinics in Asia, Latin America, North Africa, and the US indicated the |
| progesterone-releasing vaginal ring (PVR) is a safe, effective contraceptive method for lactating women. Study |
| participants, enrolled 4-9 weeks postpartum, agreed to fully or nearly fully breast feed for at least 3 months after |
| admission. The ring released an average of 10 mg of progesterone per day for a 3-month period. The Copper T |
| 380A IUD served as the non-hormonal control. A total of 431 and 533 woman-years of observation were accumulated |
| in the PVR and IUD groups, respectively. After 12 months of use, the cumulative pregnancy rate was 1.5 per 100 in |
| the PVR group and 0.5 per 100 in the IUD group. In the year following admission, 3.4% of PVR acceptors |
| complained of heavy and/or prolonged bleeding. At 12 months postpartum, 46.2% of ring users compared with only |
| one-sixth of IUD users remained amenorrheic. Although PVR acceptors reported more vaginal problems (e.g., |
| discharge or leukorrhea), pelvic examinations were more likely to detect abnormalities in IUD users. The 6- and 12- |
| month continuation rates were 52.5% and 23.5%, respectively, in the PVR group and 74.8% and 34.5%, respectively, |
| in the IUD group. The predominant reason for discontinuation was weaning. Breast feeding performance and infant |
| growth were within normal limits for the PVR and IUD. Both methods are highly effective and appropriate for use by |
| lactating women from the second postpartum month forward; the PVR has the additional advantage of being user- |
| controlled. (PubHealth.info Document ID: CONT2T 517-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Contraceptives for lactating women: a comparative trial of a |
| progesterone-releasing vaginal ring and the Copper T 380A IUD.", is(are) Sivin I; Diaz S; Croxatto HB; Miranda P; |
| Shaaban M; Sayed EH; Xiao B; Wu SC; Du MK; Alvarez F. The source of this article is "CONTRACEPTION. 1997 |
| Apr;55(4):225-32.". This article was published in 1997 in English language(s). (PubHealth.info® Document ID: |
| CONT2T 517-06. All rights reserved with PubHealth.info) PIN: 5517 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |
